Daniel Petrylak, MD, Yale Cancer Center, New Haven, CT, discusses the role of immunotherapy in patients with advanced bladder cancer, highlighting its benefit in combination with chemotherapy. This interview took place at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2022 in San Francisco, CA.